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Abstract. To determine whether jugular venous reflux (JVR) is associated with cerebral white matter changes (WMCs) in indi-
viduals with Alzheimer’s disease (AD), we studied 12 AD patients 24 mild cognitive impairment (MCI) patients, and 17 elderly
age- and gender-matched controls. Duplex ultrasonography and 1.5T MRI scanning was applied to quantify cerebral WMCs [T2
white matter (WM) lesion and dirty-appearing-white-matter (DAWM)]. Subjects with severe JVR had more frequently hyperten-
sion (p = 0.044), more severe WMC, including increased total (p = 0.047) and periventricular DAWM volumes (p = 0.008), and
a trend for increased cerebrospinal fluid volumes (p = 0.067) compared with the other groups. A significantly decreased (65.8%)
periventricular DAWM volume (p = 0.01) in the JVR-positive AD individuals compared with their JVR-negative counterparts
was detected. There was a trend for increased periventricular and subcortical T2 WMC lesion volumes in the JVR-positive AD
individuals compared with their JVR-negative counterparts (p = 0.073). This phenomenon was not observed in either the control
or MCI groups. In multiple regression analysis, the increased periventricular WMC lesion volume and decreased DAWM volume
resulted in 85.7% sensitivity and 80% specificity for distinguishing between JVR-positive and JVR-negative AD patients. These
JVR-WMC association patterns were not seen in the control and MCI groups. Therefore, this pilot study suggests that there may
be an association between JVR and WMCs in AD patients, implying that cerebral venous outflow impairment might play a role
in the dynamics of WMCs formation in AD patients, particularly in the periventricular regions. Further longitudinal studies are
needed to confirm and validate our findings.
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INTRODUCTION28
White matter changes (WMCs) with punctate and/or29
confluent WM lesions in the periventricular and/or30
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deep subcortical regions, revealed as hyperintensities 31
on T2-weighted or fluid-attenuated inversion recov- 32
ery (FLAIR) magnetic resonance imaging (MRI), are 33
strongly related to aging [1]. These age-related WMCs 34
are associated with occurrences of different types of 35
dementia including Alzheimer’s disease (AD) and pre- 36
dict faster cognitive decline not only in the general 37
population, but also in AD patients [2, 3]. 38
Jugular venous reflux (JVR), characterized by a ret- 39
rograde flow in internal jugular veins (IJVs) during 40
ISSN 1387-2877/13/$27.50 © 2013 – IOS Press and the authors. All rights reserved
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Valsalva maneuvers (VM) or spontaneously at rest, is41
found more frequently in the elderly [4–6]. Recently,42
it has been found that JVR is associated with age-43
related WMCs, particularly in posterior brain regions44
[7]. Retrograde-transmitted venous pressure associ-45
ated with JVR in the elderly is thought to result in46
accumulated insults to the cerebral vasculature, small47
vessel structure/function, and/or the brain-blood bar-48
rier, leading to WM damage [7, 8]. Compared with49
non-demented individuals, WMCs are more prevalent50
and severe in AD patients [9–14]. In this study, we51
tested the hypothesis that JVR might be involved in52
the dynamics of WMC formation in AD by evaluat-53
ing the relationship between the severity of JVR and54
WMC in patients with AD.55
MATERIAL AND METHODS56
Subjects57
Between December 2008 and April 2010, Tai-58
wanese residents consecutively admitted to a memory59
clinic at Taipei Veterans General Hospital, Taiwan60
due to subjective memory complaints were assessed61
for inclusion. Neurologists performed clinical and62
neurologic evaluations in all participants. A standard63
set of neuropsychological assessments including the64
Mini-Mental State Examination (MMSE) and Clinical65
Dementia Rating (CDR) scales were used.66
Subjects eligible for participation in the current67
study were 55 years of age or older, had a CDR score68
≤1 (as an assurance that they could cooperate dur-69
ing the VM for JVR detection), and were willing to70
receive brain MRI and neck duplex ultrasonography.71
Exclusion criteria for all subjects were a past his-72
tory of stroke, ischemic heart disease, congestive heart73
disease, valvular heart disease, cardiac arrhythmia,74
pulmonary diseases, or malignancy, and having brain75
MRI of insufficient quality for performing quantitative76
volumetric analysis.77
Vascular risk factors were defined according to inter-78
national guidelines and prospectively identified using79
all available information including medical charts, lab-80
oratory results, patient interviews, and neurological81
examinations (Supplementary Material) [15].82
Subjects were classified into AD, mild cognitive83
impairment (MCI), or control groups according to the84
criteria of National Institute of Neurological and Com-85
municative Disorders and Stroke/Alzheimer’s Disease86
and Related Disorders Association and by Petersen et87
al.’s study revised by the Stockholm consensus group88
[16–18]. The hospital’s Institutional Review Boards89
approved the study, and each included participant or 90
his/her caregiver provided informed consent. 91
Color-coded duplex ultrasonography: JVR 92
determination 93
Ultrasonographic determination of JVR has been 94
described previously (Supplementary Materials) [6, 95
7]. JVR could be detected spontaneously at rest or 96
only during VM. We graded the severity of JVR into 97
three groups. Subjects with no JVR on both IJV sides 98
were classified as a no-JVR group. Subjects with JVR 99
detected on either or both IJV sides during VM only, 100
or subjects with spontaneous JVR on one IJV side and 101
no JVR on the other IJV side were graded as the mild- 102
JVR group. Subjects with JVR detected on one IJV 103
side spontaneously at rest in combination with JVR 104
detected during VM or spontaneously at rest in the 105
other side were graded as the severe-JVR group [7]. 106
MRI acquisition 107
All study participants were scanned on 1.5T MRI 108
(Excite II; GE Medical Systems, Milwaukee, WI). 109
MRI brain sequences included axial two dimensional 110
(2D) T1- and T2-weighted imaging (WI), FLAIR 111
and three dimensional (3D) T1 spoiled gradient echo 112
(SPGR) pulse sequences. The images were acquired 113
with the following sequence parameters: for 3D T1 114
the repetition time (TR) was 8.5 ms, echo time (TE) 115
1.8 ms, inversion time (TI) 400 ms, flip angle (FA) 116
15◦, slice thickness 1.5 mm, field of view (FOV) 117
260 mm × 260 mm and matrix 256 × 256; for T2 the 118
TR was 3700 ms, TE 102 ms, echo train length 19, slice 119
thickness 3 mm, FOV 240 mm × 240 mm and matrix 120
256 × 256; for FLAIR: TR 9000 ms, TE 120 ms, 121
TI 2250 ms, slice thickness 3 mm, FOV 240 mm × 122
240 mm and matrix 256 × 256. 123
MRI image analysis 124
The MRI analysis personnel were blinded to the 125
subjects’ demographic and clinical characteristics. 126
We classified WMCs as belonging to two groups 127
of signal abnormalities based on FLAIR/T2-WI signal 128
intensity: T2 WM lesion and dirty-appearing-white- 129
matter (DAWM). The T2 WM lesion number and 130
volume on T2-WI were outlined using a semi- 131
automated edge detection contouring/thresholding 132
technique as described previously [19]. Regional local- 133
ization of WM lesion volume was determined in the 134
periventricular and deep subcortical regions. We also 135
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outlined areas of DAWM and calculated their number136
and volume. The DAWM was defined as a non-focal137
area of signal increase on the FLAIR/T2-WI, with a138
subtly increased signal intensity compared with the sig-139
nal intensity of normal appearing WM, as previously140
proposed [20]. The DAWM showed relatively diffuse141
border compared with focal T2 WM lesions and was142
tapered off toward the normal appearing WM (Fig. 1).143
The regional localization of DAWM volume was also144
determined in the periventricular and deep subcortical145
regions. The data are presented separately for number146
and volume of total and regional T2 WM lesions as147
well as DAWM.148
In addition, we used Structural Image Evalua-149
tion, using Normalisation, of Atrophy, cross-sectional150
(SIENAX, version 2.6) to estimate normalized lateral151
ventricular volume (NLVV), and normalized cere-152
brospinal fluid (CSF) volume, as previously described153
[21].154
Statistical analysis155
Statistical analysis was undertaken using a combi-156
nation of Statistical Package for the Social Sciences157
(SPSS, IBM, Armonk, New York, USA) and in-house158
algorithms written in Matlab (Mathworks, Natick,159
Mass) with the aim of evaluating the impact of JVR160
on the respective MRI variables.161
Parametric and non-parametric analyses were per-162
formed on the respective study cohorts to identify163
significant differences between the various study164
groups, including disease groups, JVR severity score,165
and JVR presence. In order to identify MRI variables166
that were associated with the presence of JVR, we167
obtained plots of the logit versus logistic function of168
the multiple regression analysis in the respective study169
groups.170
Given the exploratory pilot nature of the study, val-171
ues of p < 0.05 were considered statistically significant172
and p < 0.1 was considered a trend.173
RESULTS174
Eighty-four subjects [57–93 years of age;175
mean(SD): 79.77(7.41) years; 33 women; 31 control176
subjects, 33 MCI subjects, and 20 AD subjects] were177
eligibly enrolled according to our criteria. To match178
age and gender in each disease group, 53 subjects179
[64–91 years of age; mean(SD): 81.5 (4.50) years;180
22 women] were enrolled for further analysis. There181
were 17 control subjects, 24 MCI subjects, and 12182
AD subjects (Table 1). All the AD patients met the183
diagnostic criteria for AD and CDR = 1; and all MCI 184
patients met the diagnostic criteria for MCI and had a 185
CDR = 0.5. Twenty two subjects (41.5%) had right- 186
sided JVR (all detected during VM) and 23 subjects 187
(43.4%) had left-sided JVR (9 detected spontaneously 188
at rest and 14 detected during VM, Table 2). There 189
were 12 subjects (22.6%) with bilateral JVR; among 190
them, 5 had unilateral spontaneous JVR at rest with 191
contralateral VM-induced JVR and 7 had bilateral 192
VM-induced JVR. Twenty subjects (37.7%) presented 193
with JVR on neither side. 194
Table 1 shows the comparisons of clinical charac- 195
teristics and MRI variables between control, MCI, and 196
AD groups. From this it can be seen that for all but three 197
study variables, there was no significant difference 198
between the respective groups. The only exceptions 199
to this were: the MMSE score, which was significantly 200
lower in the AD group (p < 0.001); the number of years 201
in education, which was on average approximately 3 202
years less in the MCI and AD groups (p = 0.033); and 203
hyperlipidemia, which had a higher incidence in the 204
AD group (p = 0.014). 205
The clinical characteristics and MRI variables 206
between the three JVR-graded groups are presented in 207
Table 2, which also shows the frequencies of vascular 208
risk factors. The three JVR-graded groups were closely 209
age-matched and had similar clinical characteristics, 210
with the exception of the incidence of hypertension, 211
which was significantly greater in the mild and severe 212
JVR groups (p = 0.044). There was a general trend 213
for an increased WMC number and volume in the 214
severe-JVR group that reached significance for the 215
total DAWM (p = 0.047) and periventricular DAWM 216
volume (p = 0.008). The more severe JVR group also 217
exhibited a trend for increased CSF volumes compared 218
with the other groups (p = 0.067). 219
Further investigation, using a 2-tailed Mann Whit- 220
ney U-test (Table 3), revealed a significantly decreased 221
(65.8%) periventricular DAWM volume (p = 0.01) in 222
the JVR-positive AD individuals compared with their 223
JVR-negative counterparts. There was also a trend 224
for an increased periventricular and subcortical T2 225
WMC lesion volume in the JVR-positive AD individ- 226
uals compared with their JVR-negative counterparts 227
(p = 0.073). This phenomenon was not observed in the 228
either the control or MCI groups. 229
Figure 2 shows a plot of the logit versus logistic 230
function of the multiple regression analysis for the 231
AD patients group using the periventricular T2 WMC 232
volume (B = 0.0004) and periventricular DAWM vol- 233
ume (B = −0.0039) versus the JVR positivity score. 234
This resulted in sensitivity of 85.7% and specificity 235
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Table 1
Clinical characteristics and MRI variables between control, MCI, and AD groups
Control (n = 17) MCI (n = 24) AD (n = 12) p
Age, years, mean (SD) 81.4 (3.8) 81.4 (4.0) 81.8 (6.4) 0.968
Females, n (%) 5 (29.4) 11 (45.8) 6 (50.0) 0.457a
Education, years, mean(SD) 13.4 (1.8) 10.9 (4.4) 9.8 (4.1) 0.033
MMSE 28.1 (1.6) 26.2 (1.9) 20.4 (3.1) <0.001
Hypertension, n (%) 11 (64.7) 12 (50.0) 7 (58.3) 0.639a
Diabetes mellitus, n (%) 4 (23.5) 5 (20.8) 3 (25.0) 0.956a
Hyperlipidemia, n (%) 3 (17.6) 2 (8.3) 6 (50.0) 0.014a
Smoking, n (%) 1 (5.9) 1 (4.2) 0 (0.0) 0.709a
JVR
Positivec, n (%) 11 (64.7) 15 (62.5) 7 (58.3) 0.941a
Severity scored, mean (SD) 1.8 (0.7) 1.9 (0.8) 1.8 (0.8) 0.864b
WMC number changes, mean (SD)
T2 WM lesions + DAWM 28.1 (16.6) 44.9 (30.6) 42.6 (18.6) 0.091
T2 WM lesions 25.4 (17.3) 25.3 (16.0) 24.8 (19.9) 0.996
DAWM 18.2 (21.2) 33.4 (38.5) 31.3 (11.6) 0.246
WMC volume changes, mean(SD)
T2 WM lesions + DAWM 9.5 (12.8) 11.9 (14.7) 10.6 (16.4) 0.875
T2 WM lesions 8.6 (12.8) 10.6 (14.7) 9.5 (16.3) 0.909
Subcortical 2.5 (5.6) 2.2 (3.4) 2.2 (4.2) 0.975
Periventricular 6.1 (7.8) 8.4 (13.8) 7.4 (12.1) 0.828
DAWM 0.9 (0.9) 1.3 (1.1) 1.1 (0.6) 0.483
Subcortical 0.5 (0.6) 0.7 (0.7) 0.4 (0.3) 0.252
Periventricular 0.4 (0.4) 0.6 (0.7) 0.7 (0.5) 0.504
Normalized LV volume 77.4 (27.0) 79.5 (24.8) 91.8 (25.3) 0.294
CSF volume 374.5 (54.4) 364.0 (63.8) 367.0 (63.4) 0.860
JVR, jugular vein reflux; n, number; SD, standard deviation; %, percentage; WM, white matter; WMC, white matter changes; MCI, mild
cognitive impairment; AD, Alzheimer’s disease; DAWM, dirty-appearing white matter; LV, lateral ventricle; CSF, cerebrospinal fluid. p value
determined by one-way ANOVA unless otherwise stated. ap value determined using chi square test. bp value determined using Kruskal-Wallis
test. cThe presence of JVR in either side would be defined as JVR-positive. dJVR severity score: 1 = no JVR; 2 = mild JVR; 3 = severe JVR.
of 80% for distinguishing between JVR-positive and236
JVR-negative AD patients. Similar analysis revealed237
that none of the MRI variables were significantly asso-238
ciated with JVR positivity score in the control and MCI239
groups.240
DISCUSSION241
The present pilot study was of limited scope, having242
a small sample size with only few subjects who pre-243
sented with severe JVR. Therefore, our findings should244
be interpreted with caution and no firm conclusions245
should be made regarding the general applicability246
of our findings at this moment in time. Future stud-247
ies including larger sample size and more MCI and248
AD patients are needed to confirm the validity of our249
findings.250
The principal finding of the present study is that JVR251
appears to be associated with changes in the DAWM,252
particularly in the periventricular region. Increased253
DAWM volume, particularly in the periventricular254
region, was associated with a more severe JVR score.255
DAWM is defined as a region of intermediate signal256
intensity between that of T2 WM lesions and that 257
of normal-appearing white-matter [20, 23–27]. The 258
measurement of DAWM is relatively unexplored terri- 259
tory in neurodegenerative disorders and aging. To the 260
best of our knowledge, the present study is the first 261
of its kind to explore measurement of the DAWM in 262
elderly. Most of the work on DAWM has been per- 263
formed in patients with multiple sclerosis [20, 23–27], 264
and although the concept of DAWM remains largely 265
under investigation, it appears to have potential as a 266
diagnostic metric. Image-pathology correlation stud- 267
ies reveal DAWM, compared with T2 WM lesions, to 268
be associated with mild blood-brain barrier breakdown 269
and myelin loss [20, 23–27]. Therefore, it can be sug- 270
gested that DAWM may represent an earlier stage of 271
WM pathology in elderly [25, 26], which is followed 272
at a later stage, by T2 WM lesion formation [35–38]. 273
Indeed, using WMC lesion volumes and DAWM it 274
was possible to distinguish between the JVR-positive 275
and JVR-negative AD patients, with high degree of 276
accuracy (sensitivity = 85.7% and specificity = 80%) 277
and minimal overlap (Fig. 2). These findings sug- 278
gest that in the AD group, DAWM areas may have 279
converted into T2 WM lesions at a greater rate in 280
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Table 2
Clinical characteristics and MRI variables between three JVR-graded groups
No JVR (n = 20) Mild JVR (n = 28) Severe JVR (n = 5) p
Age, years, mean (SD) 81.1 (3.4) 81.7 (5.0) 81.6 (6.3) 0.882
Females, n (%) 8 (40.0) 13 (46.4) 1 (20.0) 0.535a
Disease classification, n (%) 0.864b
Control 6 (30.0) 10 (35.7) 1 (20.0)
MCI 9 (45.0) 12 (42.9) 3 (60.0)
AD 5 (25.0) 6 (21.4) 1 (20.0)
Education, years, mean (SD) 12.3 (4.0) 10.9 (3.8) 11.2 (4.2) 0.496
MMSE 25.1 (4.0) 25.9 (3.1) 24.8 (4.7) 0.705
Hypertension, n (%) 8 (40.0) 17 (60.7) 5 (100.0) 0.044a
Diabetes mellitus, n (%) 7 (35.0) 5 (17.9) 0 (0.0) 0.168a
Hyperlipidemia, n (%) 4 (20.0) 6 (21.4) 1 (20.0) 0.992a
Smoking, n (%) 0 (0.0) 2 (7.1) 0 (0.0) 0.395a
WMC number changes, mean (SD)
T2 WM lesions + DAWM 35.4 (20.8) 38.1 (26.9) 58.0 (26.6) 0.193
T2 WM lesions 23.1 (15.9) 25.7 (19.1) 31.0 (3.9) 0.642
DAWM 28.6 (27.4) 24.3 (32.2) 46.6 (13.6) 0.301
WMC volume changes, mean (SD)
T2 WM lesions + DAWM 7.3 (8.9) 11.3 (15.2) 21.9 (22.2) 0.119
T2 WM lesions 6.2 (8.9) 10.4 (15.2) 19.8 (22.6) 0.150
Subcortical 1.5 (3.2) 2.6 (4.7) 4.1 (6.0) 0.441
Periventricular 4.7 (7.4) 7.9 (12.6) 15.7 (17.0) 0.159
DAWM 1.1 (0.8) 0.9 (1.0) 2.1 (1.0) 0.047
Subcortical 0.5 (0.4) 0.6 (0.7) 1.0 (0.3) 0.296
Periventricular 0.7 (0.5) 0.4 (0.4) 1.1 (1.0) 0.008
Normalized LV volume 81.6 (25.9) 77.8 (24.4) 102.8 (27.4) 0.136
CSF volume 373.0 (53.0) 355.1 (61.6) 420.7 (53.3) 0.067
JVR, jugular vein reflux; n, number; SD, standard deviation; %, percentage; WM, white matter; WMC, white matter changes; MCI, mild
cognitive impairment; AD, Alzheimer’s disease; DAWM, dirty-appearing white matter; LV, lateral ventricle; CSF, cerebrospinal fluid. Volumes
are expressed in milliliters. p value determined by one-way ANOVA unless otherwise stated. ap value determined using chi square test. bp value
determined using Kruskal-Wallis test.
subjects with more severe JVR (Table 3). However,281
future longitudinal studies are necessary to elucidate282
the chronological JVR effects on WMC formation in283
AD patients.284
The present study suggests that periventricular285
WMCs may be associated with JVR (Tables 2 and 3).286
This regional-association was not shown in our pre-287
vious study [7], possibly because: (1) the volumetric288
and DAWM approaches used in this study were more289
sensitive to small group differences than the WMC290
visual-rating scale used previously [20, 22–27]; or291
(2) there were differences in the severe-JVR popula-292
tions of the groups that were used in the two studies293
[7]. Why the periventricular region in AD patients294
could be influenced by JVR is something unknown295
at this time. However, there is evidence that venous296
drainage anomalies can influence CSF dynamics, slow-297
ing down CSF absorption into the superior sagittal298
sinus [39]. The lateral ventricles represent the major299
reservoir of CSF in the brain. It has been proposed300
that retrograde-transmitted venous pressure, caused by301
JVR, may induce venous hypertension in the superior302
sagittal sinus, resulting in decreased CSF absorption303
and larger lateral ventricle volume [28–31] and CSF 304
volume, as evidenced in the present study. However, 305
this association has to be further investigated. 306
The etiology of WMC in AD is still uncertain. Our 307
pilot results suggest that DAWM may be a precursor 308
to T2 lesion formation and that transition between the 309
two might be accelerated by the presence of JVR. It 310
may be that JVR alters the intracranial biomechanics 311
interacting synergistically with other AD pathologies. 312
That these associations were not observed in either the 313
MCI subjects or controls may suggest that JVR may 314
play some role in late AD pathophysiology. It has been 315
reported that retrogradely transmitted venous hyper- 316
tension in AD patients associated with JVR might: 317
(1) decrease cerebral perfusion, damage small vessel 318
structure/function, and possibly damage the blood- 319
brain barrier [8]; or (2) impair CSF absorption, thus 320
reducing CSF net flow, enlarging ventricles, and possi- 321
bly lowering amyloid- clearance with the result that 322
it accumulates in the periventricular tissues [32–34]. 323
Either one or both of these mechanisms might con- 324
tribute to WMC formation in AD patients. However, 325
at this stage it is not possible to ascertain this, and 326
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Table 3
MRI variables classified according to JVR status (i.e., positive or negative)
JVR-negative JVR-positive p
Controls, n (%) 6 (30.0) 11 (70.0) NA
WMC number changes, mean (SD)
T2 WM lesions + DAWM 24.2 (16.7) 30.3 (17.0) 0.509
T2 WM lesions 21.5 (14.3) 27.5 (19.1) 0.713
DAWM 13.8 (10.3) 20.5 (25.4) 0.831
WMC volume changes, mean (SD)
T2 WM lesions + DAWM 3.9 (3.4) 12.6 (15.1) 0.216
T2 WM lesions 3.3 (3.1) 11.5 (15.2) 0.256
Subcortical 0.7 (0.9) 3.5 (6.9) 0.538
Periventricular 2.6 (2.5) 8.0 (9.1) 0.216
DAWM 0.6 (0.4) 1.1 (1.1) 0.612
Subcortical 0.3 (0.2) 0.6 (0.7) 0.675
Periventricular 0.4 (0.3) 0.4 (0.4) 0.904
Normalized LV volume 69.0 (23.1) 82.0 (28.9) 0.525
CSF volume 348.0 (49.7) 389.0 (53.4) 0.216
MCI, n (%) 9 (45.0) 15 (55.0) NA
WMC number changes, mean (SD)
T2 WM lesions + DAWM 35.4 (19.9) 50.5 (35.0) 0.633
T2 WM lesions 26.3 (18.2) 24.7 (15.1) 0.743
DAWM 37.9 (37.6) 30.7 (40.0) 0.455
WMC volume changes, mean (SD)
T2 WM lesions + DAWM 11.4 (12.0) 12.2 (16.4) 0.952
T2 WM lesions 10.1 (12.2) 10.9 (16.4) 1.000
Subcortical 2.7 (4.6) 2.0 (2.6) 0.905
Periventricular 7.4 (10.4) 9.0 (15.7) 0.858
DAWM 1.3 (1.0) 1.3 (1.2) 0.698
Subcortical 0.7 (0.6) 0.7 (0.8) 0.952
Periventricular 0.6 (0.6) 0.5 (0.8) 0.426
Normalized LV volume 85.8 (29.6) 75.6 (21.6) 0.474
CSF volume 377.3 (54.2) 356.0 (69.4) 0.512
AD, n (%) 5 (25.0) 7 (75.0) NA
WMC number changes, mean (SD)
T2 WM lesions + DAWM 48.8 (22.5) 38.1 (15.5) 0.505
T2 WM lesions 19.2 (15.5) 28.9 (22.7) 0.530
DAWM 29.4 (8.6) 32.6 (13.9) 0.861
WMC volume changes, mean (SD)
T2 WM lesions + DAWM 4.2 (2.2) 15.2 (20.7) 0.202
T2 WM lesions 2.8 (1.8) 14.4 (20.4) 0.073
Subcortical 0.3 (0.4) 3.5 (5.2) 0.073
Periventricular 2.5 (1.6) 10.9 (15.2) 0.073
DAWM 1.4 (0.7) 0.8 (0.5) 0.106
Subcortical 0.3 (0.3) 0.4 (0.4) 0.755
Periventricular 1.1 (0.4) 0.4 (0.2) 0.010
Normalized LV volume 88.9 (20.6) 93.8 (29.7) 0.876
CSF volume 395.4 (53.0) 346.8 (66.2) 0.268
JVR, jugular vein reflux; n, number; SD, standard deviation; %, percentage; WM, white matter; WMC, white matter changes; MCI, mild
cognitive impairment; AD, Alzheimer’s disease; DAWM, dirty-appearing white matter; LV, lateral ventricle; CSF, cerebrospinal fluid; NA, not
available. Volumes are expressed in milliliters. p values determined by 2-tailed Mann Whitney U-test.
further investigation is required before any causal link327
between JVR in AD pathology can be claimed. Our328
findings may serve as an important pilot data in this329
direction.330
It is noticeable that JVR appears to be associated331
with certain cardiovascular risk factors, e.g., hyperten-332
sion. Dolic et al. [40] studied 240 healthy individuals333
and found that the presence of heart disease, especially334
heart murmurs, obesity, and cigarette smoking were 335
associated with an increased prevalence of extracra- 336
nial venous abnormalities. These results, in addition 337
to the findings from the present study, may imply that 338
cardiovascular or systemic metabolic disorders may 339
be involved in the pathophysiology of venous (espe- 340
cially IJV) hemodynamic abnormalities. Besides, it is 341
known that patients with hypertension have less venous 342
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Fig. 1. Examples of periventricular and subcortical white matter T2 lesions and dirty appearing white matter (DAWM) in controls, mild cognitive
impairment (MCI) patients, and Alzheimer’s disease patients.
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Fig. 2. Plot of the logit versus logistic function for the AD
patients group using the variables periventricular T2 WMC volume
(B = 0.0004) and periventricular DAWM volume (B = −0.0039).
Logit = 0.5 is deemed to separate the JVR-positive subjects from
the negative subjects. This results in one false positive and one false
negative (sensitivity = 85.7% and specificity = 80%). JVR, jugular
vein reflux; AD, Alzheimer’s disease; WMC, white matter change;
DAWM, dirty-appearing white matter.
distensibility [41, 42]. One characteristic specific for 343
venous walls is that they have greater distensibility 344
than arterial walls which makes them able to accom- 345
modate a greater range of increased venous pressure 346
[43]. Decreased venous distensibility in hypertension 347
might reduce this pressure buffer ability in IJV and 348
repetitive higher venous pressure might damage IJV 349
valvular structure and its competence, leading to more 350
frequent JVR seen in patients with hypertension. 351
It should be noted that this pilot study had a relatively 352
small sample size and that future larger case-control 353
studies are needed to elucidate the differences of WMC 354
severity between AD, MCI, and control groups. In 355
addition, another limitation of the study is related to its 356
cross-sectional nature, and further longitudinal studies 357
are needed to determine temporal relationship between 358
JVR and WMC lesion formation in relation to DAWM, 359
particularly in the periventricular regions. 360
In conclusion, the findings of our pilot study showed 361
that cerebral venous drainage impairment may play 362
some role in the pathophysiology of WMC in the AD 363
patients.
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